ADMA Biologics Announces BioCareSD Selected as Primary Authorized Distributor of ASCENIV™ and First Commercial Sales

Post Date: October 21, 2019

BioCareSD has been selected by ADMA Biologics, Inc. as the primary authorized national distributor for ASCENIV. ASCENIV is a plasma-derived, polyclonal human immune globulin product.  ASCENIV is indicated for the treatment of Primary Humoral Immunodeficiency or...

BioCareSD Selected Primary Authorized Distributor for BIVIGAM®

Post Date: September 16, 2019

BioCareSD has been selected by ADMA Biologics, Inc. as the primary authorized national distributor for BIVIGAM®. BIVIGAM®[Immune Globulin Intravenous (Human), 10% Liquid] is indicated for the treatment of primary humoral immunodeficiency (PI). Linda Matthews, president of BioCareSD,...

Linda Matthews Named One Of The 2018 PM360 ELITE 100

Post Date: May 24, 2017

PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, and medical device sectors, has named Linda Matthews, President, BioCareSD, Inc., as one of the 2018 PM360 ELITE 100 in the Transformational...

BioCare to Become Separate Company January 1, 2017

Post Date: January 1, 2017

Blood Systems, Incorporated has announced that the operations of BioCare, its plasma and biological therapeutics sales division, will be transferred to BioCare, Inc., a separate, for-profit subsidiary of Blood Systems, effective January 1, 2017. Blood...

BioCare Selected as Exclusive Distributor for Ceprotin

Post Date: October 27, 2016

Manufacturer Shire has named BioCare as the exclusive, national authorized distributor for CEPROTIN, a Protein C concentrate replacement therapy. It is indicated for the prevention and treatment of venous thrombosis and purpura fulminans for pediatric and...

Octapharma’s NUWIQ Available at BioCare

Post Date: January 15, 2016

BioCare is excited to announce that Octapharma’s NUWIQ is now available. NUWIQ is the first and only recombinant FVIII produced in human cells without chemical modification. It is indicated in children and adults with Hemophilia A for on-demand treatment...

BioCare Named as Distributor for COAGADEX® for the Treatment of Hereditary Factor X Deficiency

Post Date: October 12, 2015

BioCare announced that it has been named by Bio Products Laboratory Limited (BPL) as a distributor for Coagadex (coagulation factor X, human). Product is available for shipment. Coagadex was approved by the U.S. Food and Drug...

BioCare Parent Company Named One of Arizona Business Magazine’s 40 Most Admired Companies

Post Date: September 21, 2015

Blood Systems, the parent company of BioCareSD, has been selected by Arizona Business Magazine and BestCompaniesAZ as one of 40 winners of the 2015 Arizona’s Most Admired Companies Awards (MAC) and is featured in the...

BioCare Provides Electronic Portal Solution for Prescription Drug Pedigrees

Post Date: July 1, 2015

The USDSCSA (United States Drug Supply Chain Security Act) requires product and transaction information  for all sales of prescription drug products sold by a distributor or manufacturer effective July 1,  2015. Manufacturers and distributors are required to provide...

Baxter Selects BioCare as Exclusive Distributor for OBIZUR

Post Date: December 16, 2014

BioCare has been selected by Baxter as the exclusive, national authorized distributor for OBIZUR, the only recombinant porcine sequence factor VIII replacement treatment for acquired hemophilia A (AHA). OBIZUR was approved by the FDA for...